Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Serotonergic psychedelics induce distinct patterns of metabolic activity and covariance within biologically informed rat brain networksNature Communications · 2026-08-03Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trialCommunications Medicine · 2026-07-30Changes in Self-awareness Induced by Psychoactive Substances: an Experimental Study With Psilocybin.ClinicalTrials.gov · 2026-07-28CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorderNeuropsychopharmacology · 2026-07-07Trajectories of psychedelic-assisted change: An observational study of a psilocybin retreat program followed by psychotherapeutic interventionsJournal of Psychedelic Studies · 2026-07-03Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participantsNeuropsychopharmacology · 2026-07-01Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges.Journal of psychiatric research · 2026-06-23Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New MexicoFrontiers in Public Health · 2026-06-17Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-AnalysisPsychiatry International · 2026-06-15THE PSYCHEDELIC AND KETAMINE RENAISSANCE IN THE FACE OF THE CRISIS IN MODERN PSYCHIATRYInternational Journal of Innovative Technologies in Social Science · 2026-06-14From Altered States to Altered Trajectories and From Molecules to Meaning: A Network Meta Analysis Mapping Comparative Efficacy of Psychedelic Assisted Therapies in Modern PsychiatryBJPsych Open · 2026-06-01Impact of formulation variables on the quality attributes of psilocybin-loaded oral thin films for early-phase developmentJournal of Drug Delivery Science and Technology · 2026-06-01Reorganization of Human Brain Waves Across Diverse States of Consciousness.bioRxiv: the preprint server for biology · 2026-06-01Psilocybin restores behavioral and neuroplastic deficits induced by chronic stress in ratsProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2026-06-01Psilocybin-Assisted Therapy in Depressive Disorders: Efficacy, Safety, and Persistence of Clinical Effects - A Narrative ReviewJournal of Education, Health and Sport · 2026-05-07Acute Effects of 4-Bromo-2,5-Dimethoxyphenethylamine (2C-B) Compared With Psilocybin and MDMA in Healthy ParticipantsBiological Psychiatry · 2026-05-01PDE4B Inhibition and Psilocybin as Promising Approaches for Treating Methamphetamine Use Disorder: Preclinical Evidence From Rat Models (Abstract ID: 232554)The Journal of Pharmacology and Experimental Therapeutics · 2026-05-01A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorderJournal of Psychopharmacology · 2026-05-01Psychedelics: Historical Context, Emerging Science, and Future Clinical FrontiersJournal of Mental Health Disorders · 2026-04-18Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depressionBMC Medical Education · 2026-04-09Complete biosynthesis of psychedelic tryptamines from three kingdoms in plants.Science advances · 2026-04-03Psilocybin Production With Genetically Modified Aspergillus nidulans Under Pressurized Conditions.Biotechnology and bioengineering · 2026-04-01THE EFFECT OF PSILOCYBIN AND EUGENOL ON LIPOPOLYSACCHARIDE INDUCED INFLAMMATION IN SMALL AND LARGE INTESTINE OF MICEZenodo (CERN European Organization for Nuclear Research) · 2026-03-01Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.Open Access CRIS of the University of Bern · 2026-01-21Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.JAMA network open · 2026-01-02Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trials.Journal of psychopharmacology (Oxford, England) · 2026-01-01Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs.Journal of psychopharmacology (Oxford, England) · 2026-01-01Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathwayNaunyn-Schmiedeberg's Archives of Pharmacology · 2025-10-01Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression - comparison with ketamine, fluoxetine and lithium.Journal of psychopharmacology (Oxford, England) · 2025-09-01Cross-Species Evidence for Psilocin-Induced Visual Distortions: Apparent Motion Is Perceived by Both Humans and RatsBiological Psychiatry Global Open Science · 2025-09-01Psychedelic and Medicinal Mushrooms: Potent Source of Active Metabolites and MedicinesCurrent Bioactive Compounds · 2025-07-02Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre-Administration in a Randomized, Double-Blind, Cross-Over Phase I Trial.Clinical pharmacology and therapeutics · 2025-06-01Exploring psilocybin's role in mental health and palliative medicine: a path to improved well-being.Expert opinion on emerging drugs · 2025-06-01Polysubstance Use Profiles Among the General Adult Population, United States, 2022.American journal of public health · 2025-05-010391 Racial/Ethnic Differences in Psychedelic Use and Sleep Satisfaction: Preliminary Findings from the Herbal Heart StudySLEEP · 2025-04-30LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice.Pharmaceuticals (Basel, Switzerland) · 2025-03-23Risks of using psilocybin in treatment of treatment-resistant depressionJournal of Education Health and Sport · 2025-03-06Molecular insights into the modulation of the 5 HT2 A receptor by serotonin, psilocin, and the G protein subunit GqαFEBS Letters · 2025-03-01Correction: Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc AnalysisClinical Pharmacokinetics · 2025-03-01BROAD SPECTRUM OF THERAPEUTIC PROPERTIES OF PSILOCYBIN: A LITERATURE REVIEWHealth Problems of Civilization · 2025-02-20Setting the Stage for the Inner Journey: Unraveling the Interplay of Contextual Factors and the Intensity of Psychedelic-Induced Ego Dissolution.Journal of psychoactive drugs · 2025-02-13DETERMINATION OF TRYPTAMINE ALKALOIDS AND THEIR STABILITY IN PSYCHOTROPIC MUSHROOMSThe International Journal of Neuropsychopharmacology · 2025-01-31In Silico Evaluation of Tryptamine-Derived Schiff Bases as Modulators of the Serotonin 5-HT₂A ReceptorBook of Proceedings · 2025-01-01Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc AnalysisClinical Pharmacokinetics · 2025-01-01Psilocybin alleviates high-glucose and high-lipid-induced skin aging in BJ5Ta fibroblasts.Biochemistry and cell biology = Biochimie et biologie cellulaire · 2025-01-01Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trial.PloS one · 2025-01-01Advancing drug safety in psychiatry: insights from pharmacogenomics of hypersensitivity reactions.Frontiers in pharmacology · 2025-01-01Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis.Frontiers in psychiatry · 2025-01-01Classification of psychedelics and psychoactive drugs based on brain-wide imaging of cellular c-Fos expression.bioRxiv: the preprint server for biology · 2024-11-23Novel treatments for anorexia nervosa: Insights from neuroplasticity research.European eating disorders review: the journal of the Eating Disorders Association · 2024-11-01Optimized psilocybin production in tryptophan catabolism-repressed fungi.Microbial biotechnology · 2024-11-01Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms.Molecular psychiatry · 2024-10-01Insights into the efficacy of psilocybin in treating depression and other disordersBritish Journal of Neuroscience Nursing · 2024-08-01Molecular insights into the modulation of the 5HT 2A receptor by serotonin, psilocin, and the G protein subunit GqαbioRxiv · 2024-07-24Licit use of illicit drugs for treating depression: the pill and the process.The Journal of clinical investigation · 2024-06-171. Psilocybin and 4-Bromo-2,5-Dimethoxyphenethylamine (2C-B) at Encoding Distort Episodic Familiarity and Positively Bias Emotional MetamemoryBiological Psychiatry · 2024-04-29In vitro and in vivo metabolism of psilocybin’s active metabolite psilocinFrontiers in Pharmacology · 2024-04-29Genetic regulation of L-tryptophan metabolism in Psilocybe mexicana supports psilocybin biosynthesis.Fungal biology and biotechnology · 2024-04-25Antidepressant- and anxiolytic-like activities and acute toxicity evaluation of the Psilocybe cubensis mushroom in experimental models in mice.Journal of ethnopharmacology · 2024-02-10The Impact of Psilocybin on High Glucose/Lipid-Induced Changes in INS-1 Cell Viability and Dedifferentiation.Genes · 2024-01-29The Effects of Psilocybin on Lipopolysaccharide-Induced Inflammation in THP-1 Human MacrophagesPsychoactives · 2024-01-28Psilocybin and eugenol prevent DSS-induced neuroinflammation in miceBiocatalysis and Agricultural Biotechnology · 2024-01-25Psilocybin Without Psychotherapy: A Cart Without a Horse?The American journal of psychiatry · 2024-01-01Theorizing that Psychedelic Assisted Therapy May Play a Role in the Treatment of Trauma-Induced Personality Disorders.Journal of addiction psychiatry · 2024-01-01Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.Frontiers in psychiatry · 2024-01-01Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview.American journal of therapeutics · 2024-01-01Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin.American journal of therapeutics · 2024-01-01Critical appraisal of evidence supporting prescription of psychedelics from clinic websites in Ontario, Canada.PloS one · 2024-01-01Mystical and Affective Aspects of Psychedelic Use in a Naturalistic Setting: A Linguistic Analysis of Online Experience Reports.Journal of psychoactive drugs · 2024-01-01Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and OverviewPsyArXiv · 2023-12-26Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. PsilocybinPsyArXiv · 2023-12-26CROSS-SPECIES EVIDENCE FOR PSILOCIN-INDUCED VISUAL HALLUCINATIONS: RATS PERCEIVE QUALITATIVELY SIMILAR CHANGES AS HUMANSIBRO Neuroscience Reports · 2023-10-01Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2023-10-01Self-perception and self-recognition while looking in the mirror on psilocybinJournal of Psychedelic Studies · 2023-09-19Psilocybin intoxication did not affect daytime or sleep-related declarative memory consolidation in a small sample exploratory analysis.European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology · 2023-09-01Psychedelics, With a Focus on Psilocybin: Issues for the Clinician.Journal of psychiatric practice · 2023-09-01Psychedelic Use Among Psychiatric Medication Prescribers: Effects on Well-Being, Depression, Anxiety, and Associations with Patterns of Use, Reported Harms, and Transformative Mental States.Psychedelic medicine (New Rochelle, N.Y.) · 2023-09-01The molecular basis of the antidepressant action of the magic mushroom extract, psilocinBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics · 2023-07-01Alterations to self consciousness during mindfulness meditation and Flotation REST a comparative studyPsyArXiv · 2023-06-30Cardiac Arrest Associated With Psilocybin Use and Hereditary Hemochromatosis.Cureus · 2023-05-01The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice.Molecules (Basel, Switzerland) · 2023-03-14Discovering the Potential Mechanisms of Medicinal Mushrooms Antidepressant Activity: A Review.Antioxidants (Basel, Switzerland) · 2023-03-02Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines.Neuropharmacology · 2023-03-01Interaction of psychedelic tryptamine derivatives with a lipid bilayer.Chemistry and physics of lipids · 2023-03-01Effect of co-administration of low doses of psilocybin and mGluR2/3 antagonist LY341495 in chronic restraint stress model of depressionNeuroscience Applied · 2023-01-01Electrophysiological study of visual and auditory processing in psilocin-induced hallucinations: exploring evoked potentials and 5-HT2A receptor involvementNeuroscience Applied · 2023-01-01Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial.Frontiers in psychiatry · 2023-01-01Psychedelic Assisted Psychotherapy preparing your target using psychohistoriography: a Jamaican perspective.Frontiers in psychiatry · 2023-01-01A Proposal to Study the Safety and Efficacy of in Preclinical and Clinical Studies as a Therapeutic Alternative for Major Depressive Disorder.Journal of psychoactive drugs · 2023-01-01Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.Frontiers in psychiatry · 2023-01-01Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids.International journal of molecular sciences · 2022-11-15Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.The New England journal of medicine · 2022-11-03Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-17Magic mushroom extracts in lipid membranes.Biochimica et biophysica acta. Biomembranes · 2022-09-01Natural language signatures of psilocybin microdosing.Psychopharmacology · 2022-09-01Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study.Translational psychiatry · 2022-08-02Genetic Survey of Psilocybe Natural Products.Chembiochem: a European journal of chemical biology · 2022-07-19Natural language signatures of psilocybin microdosingbioRxiv · 2022-02-22The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.Journal of psychopharmacology (Oxford, England) · 2022-01-01Phenomenological assessment of psychedelics induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI).PloS one · 2022-01-01Psilocybin sex-dependently reduces alcohol consumption in C57BL/6J mice.Frontiers in pharmacology · 2022-01-01Microevidence for microdosing with psilocybin mushrooms: a double-blind placebo-controlled study of subjective effects, behavior, creativity, perception, cognition, and brain activitybioRxiv · 2021-12-07Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism.Science advances · 2021-11-19Psychedelic-Assisted Psychotherapy Practices and Human Caring Science: Toward a Care-Informed Model of TreatmentJournal of Humanistic Psychology · 2021-04-23Chemoenzymatic Synthesis of 5-Methylpsilocybin: A Tryptamine with Potential Psychedelic Activity.Journal of natural products · 2021-04-23Phenomenological assessment of psychedelic induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)PsyArXiv · 2021-04-02Phenomenological assessment of psychedelic induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)PsyArXiv · 2021-04-02Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensis.Drug testing and analysis · 2021-02-01Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.Frontiers in psychiatry · 2021-01-01The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant ActionInstitutional Repositories DataBase (IRDB) · 2020-12-03Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2020-11-01Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin.Chemistry (Weinheim an der Bergstrasse, Germany) · 2020-07-02S-Adenosyl-l-Methionine Salvage Impacts Psilocybin Formation in "Magic" Mushrooms.Chembiochem: a European journal of chemical biology · 2020-05-04Simultaneous Production of Psilocybin and a Cocktail of β-Carboline Monoamine Oxidase Inhibitors in "Magic" Mushrooms.Chemistry (Weinheim an der Bergstrasse, Germany) · 2020-01-13The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action.Frontiers in pharmacology · 2020-01-01Enzymatic Route toward 6-Methylated Baeocystin and Psilocybin.Chembiochem: a European journal of chemical biology · 2019-11-18Production Options for Psilocybin: Making of the Magic.Chemistry (Weinheim an der Bergstrasse, Germany) · 2019-01-18Iterative l-Tryptophan Methylation in Psilocybe Evolved by Subdomain Duplication.Chembiochem: a European journal of chemical biology · 2018-10-18Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar ratsBehavioural Pharmacology · 2018-09-01Biocatalytic Production of Psilocybin and Derivatives in Tryptophan Synthase-Enhanced Reactions.Chemistry (Weinheim an der Bergstrasse, Germany) · 2018-07-17Facile assembly and fluorescence-based screening method for heterologous expression of biosynthetic pathways in fungi.Metabolic engineering · 2018-07-01Enzymatic Synthesis of Psilocybin.Angewandte Chemie (International ed. in English) · 2017-09-25Enzymatische Synthese von PsilocybinAngewandte Chemie · 2017-08-01Developing Guidelines and Competencies for the Training of Psychedelic TherapistsJournal of Humanistic Psychology · 2017-06-29Phylogenetic and chemical studies in the potential psychotropic species complex of Psilocybe atrobrunnea with taxonomic and nomenclatural notes.Persoonia · 2015-06-01Psychedelics not linked to mental health problems or suicidal behavior: a population study.Journal of psychopharmacology (Oxford, England) · 2015-03-01Substance use initiation: the role of simultaneous polysubstance use.Drug and alcohol review · 2013-01-01Over 30 million psychedelic users in the United States.F1000Research · 2013-01-01Psychedelics and mental health: a population study.PloS one · 2013-01-01Determining the subjective effects of TFMPP in human males.Psychopharmacology · 2010-08-01[Hallucinogenic fungi (psilocybe). Part II. Identification of Psilocybe semilanceata by PCR].Archiwum medycyny sadowej i kryminologii · 2007-01-01Psilocin multiple intake resulted and in cardiotoxic effectsActa Toxicologica · 2006-01-01[Levels of psilocybin and psilocin in various types of mushrooms].Soudni lekarstvi · 2003-07-01Electrocardiographic examination of heart function in rats exposed to hallucinogens from Psilocybe mushroomsActa Toxicologica · 2003-01-01[Consumption of psilocybin-containing hallucinogenic mushrooms by young people].Ugeskrift for laeger · 1992-09-21Hallucinogens potentiate responses to serotonin and norepinephrine in the facial motor nucleus.Life sciences · 1980-03-30Hallucinogenic indoleamines: Preferential action upon presynaptic serotonin receptors.Psychopharmacology communications · 1975-01-01Underlying mechanism of psilocybin induced psychosisActa Universitatis Palackianae Olomucensis Facultatis Medicae · 1974-07-05Different reaction of focal and diffuse epileptic EEG activity to psilocybin.Activitas nervosa superior · 1971-01-01EEG changes after psilocybin in organic brain lesions.Activitas nervosa superior · 1971-01-01